Company news

Equillium, Inc. news in 2020

Equillium, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer

December 20, 2020

Equillium Provides Itolizumab COVID-19 Program Update

November 24, 2020

Equillium Reports Third Quarter 2020 Financial Results and Business Highlights

November 9, 2020

Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease

November 5, 2020

Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial

October 28, 2020

Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients

September 14, 2020

Equillium Announces Closing of Public Offering of Common Stock

August 17, 2020

Equillium Announces Proposed Public Offering of Common Stock

August 12, 2020

Equillium Announces Pricing of Public Offering of Common Stock

August 12, 2020

Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights

August 11, 2020

Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study

August 9, 2020

Equillium Reports First Quarter 2020 Financial Results

May 12, 2020

Equillium Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital

March 29, 2020

Equillium Strengthens Leadership Team with Key Appointments

February 26, 2020

Decks in 2020